Anika Therapeutics ANIK
NASDAQ ANIK
$19.94 -0.74 (-3.55%)
At close: Sep 29, 2026 · 4:00 PM EDT

Anika Therapeutics (ANIK) Research & Development (2010 - 2026)

Updated

Anika Therapeutics (ANIK) posted Research & Development of $7.34 million for Q2 2026, up 16.3% from $6.31 million a year earlier and up 9.4% from the prior quarter.

Analysis

Anika Therapeutics (ANIK) Research & Development (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Research & Development at Anika Therapeutics was $27.45 million, up 10.6% year-over-year; for FY2025, it was $25.77 million, up 0.9% from FY2024.

  • Annual Research & Development has increased for three consecutive years, with a five-year compound annual growth rate of 1.9% (FY2020 to FY2025).
  • In prior years, Anika Therapeutics' Research & Development was $25.54 million in FY2024 (+17.4%), $21.76 million in FY2023 (+18.8%), $18.32 million in FY2022 (-33.0%) and $27.33 million in FY2021 (+16.6%).
  • The Q2 2026 figure stands as the highest quarterly Research & Development since Q3 2023.
  • On a year-over-year basis, Research & Development increased in three of the last seven quarters, with growth averaging 1.2%.
  • The strongest year-over-year quarter for Research & Development in the past five years was Q3 2021, with growth of 47.1%; the weakest was Q2 2024, with a decline of 25.0%.
  • According to Business Quant data, Research & Development for the three prior quarters was $6.71 million (Q1 2026), $6.45 million (Q4 2025) and $6.95 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Thermo Fisher Scientific 250.84 Bn 229.99 Bn 4.88 Bn 364.00 Mn
2 Abbott Laboratories 174.73 Bn 145.82 Bn 7.27 Bn 892.00 Mn
3 Danaher 159.85 Bn 143.67 Bn 3.61 Bn 412.00 Mn
4 Intuitive Surgical 146.79 Bn 126.35 Bn 1.96 Bn 370.60 Mn
5 Medtronic 114.54 Bn 80.41 Bn 6.34 Bn 771.00 Mn
6 Stryker 105.67 Bn 91.79 Bn 4.50 Bn 434.00 Mn
7 Boston Scientific 63.93 Bn 58.94 Bn 3.85 Bn 554.00 Mn
8 Becton Dickinson 50.12 Bn 47.27 Bn 2.32 Bn 258.00 Mn
9 Edwards Lifesciences 50.06 Bn 34.17 Bn 1.35 Bn 278.90 Mn
10 Anika Therapeutics 276.76 Mn 10.21 Mn 21.24 Mn 7.34 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.34 Mn
Mar 31, 2026 6.71 Mn
Dec 31, 2025 6.45 Mn
Sep 30, 2025 6.95 Mn
Jun 30, 2025 6.31 Mn
Mar 31, 2025 6.06 Mn
Dec 31, 2024 6.51 Mn
Sep 30, 2024 5.95 Mn
Jun 30, 2024 6.68 Mn
Mar 31, 2024 6.41 Mn
Dec 31, 2023 -3.34 Mn
Sep 30, 2023 7.79 Mn
Jun 30, 2023 8.91 Mn
Mar 31, 2023 8.40 Mn
Dec 31, 2022 -2.11 Mn
Sep 30, 2022 7.30 Mn
Jun 30, 2022 6.98 Mn
Mar 31, 2022 6.16 Mn
Dec 31, 2021 6.00 Mn
Sep 30, 2021 7.67 Mn
API Access

Anika Therapeutics Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=ANIK&period=max&api_key=YOUR_API_KEY